The 27 references in paper E. Chernykh R., E. Kurganova V., M. Tikhonova A., E. Laskavaya G., V. Lebedeva A., A. Ostanin A., Е. Черных Р., Е. Курганова В., М. Тихонова А., Е. Ласкавая Г., В. Лебедева А., А. Останин А. (2014) “ВЗАИМОСВЯЗЬ РЕГУЛЯТОРНЫХ Т-КЛЕТОК С УРОВНЕМ СА-125 И ОБЪЕМОМ ОПУХОЛЕВОЙ МАССЫ У БОЛЬНЫХ РАКОМ ЯИЧНИКОВ // RELATION BETWEEN REGULATORY T CELLS, CA-125 LEVEL AND TUMOR MASS IN OVARIAN CANCER PATIENTS” / spz:neicon:mimmun:y:2010:i:5:p:311-318

1
Курганова Е.В., Тихонова М.А., Коваленко В.Ф., Лебедева В.А., Ласкавая Е.Г., Останин А.А., Черных Е.Р. Характеристика регуляторных Т-клеток у больных раком яичника // Сибирский онкологический журнал. – 2008. – No 6 (30). – С. 40-45.
(check this in PDF content)
2
Курганова Е.В., Тихонова М.А., Ласкавая Е.Г., Лебедева В.А., Звездина Н.Ю., Безбородова В.И., Гончаров М.А., Лебедева В.А., Останин А.А., Черных Е.Р. Регуляторные Т-клетки при доброкачественных и злокачественных опухолях яичников // Иммунология. – 2009. – No 6. – С. 349-355.
(check this in PDF content)
3
Сергеева Н.С., Ермошина Н.В., Мишунина М.П. Использование опухолеассоциированных маркёров для диагностики и контроля за эффективностью терапии у больных с распространенным раком яичников // М.: МНИОИ им. П.А. Герцена, 2002.
(check this in PDF content)
4
Allan S.E., Crome S.Q., Crellin N.K., Passerini L., Steiner T.S., Bacchetta R., Roncarolo M.G., Levings M.K. Activation-induced FoxP3 in human T effector cells does not suppress proliferation or cytokine production // Intern. Immunol. – 2007. – Vol. 19. – P. 345-354.
(check this in PDF content)
5
Bast R.S., Feeney M., Lazarus H., Nadler L.M., Colvin R.B., Knapp R.C. Reactivity of a monoclonal antibody with human ovarian carcinoma // J. Clin. Invest.– 1981. – Vol. 68. – P. 1331-1337.
(check this in PDF content)
6
Beyer M., Schultze J.L. Regulatory T cells in cancer // Blood. – 2006. – Vol. 108, No 3. – P. 804811.
(check this in PDF content)
7
Bonelli M., Savitskaya A., Steiner C.-W., Rath E., Smolen J.S., Scheinecker C. Phenotypic and functional analysis of CD4+CD25–Foxp3+ T cells in patients with systemic lupus erythematosus // J. Immunol. – 2009. – Vol. 182. – P. 1689-1695.
(check this in PDF content)
8
Canney P.A., Moore M., Wilkinson P.M., James R.D. Ovarian cancer antigen CA-125: a prospective clinical assessment of its role of a tumor marker // Br. J. Cancer. – 1984. – Vol. 50, N 6. – P. 765-769.
(check this in PDF content)
9
Chaput N., Louafi S., Bardier A., Charlotte F., Vaillant J-C., Menegaux F., Rosenzwajg M., Lemoine F., Klatzmann D., Taieb J. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue // Gut. – 2009. – Vol. 58, N 4. – P. 520529.
(check this in PDF content)
10
Chattopadhyay S., Chakraborty N.G., Mukherji B. Regulatory T cells and tumor immunity // Can. Immunol. Immunother. – 2005. – Vol. 54. – P. 1153 – 1161.
(check this in PDF content)
11
Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., Wahl S.M. Conversion of peripheral CD4+CD25– naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor FoxP3 // J. Exp. Med. – 2003. – Vol. 198. – P. 1875-1886.
(check this in PDF content)
12
Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J.R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M.L., Knutson K.L., Chen L., Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival // Nat. Med. – 2004. – Vol. 10, N 9. – P. 942-949.
(check this in PDF content)
13
Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells // Nat. Immunol. – 2003. – Vol. 4. – P. 330-336.
(check this in PDF content)
14
Gadducci A., Cosio S., Tana R., Genazzani A.R. Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer // Crit. Rev. Oncol. Hematol. – 2009. – Vol. 69, N 1. – P. 12-27.
(check this in PDF content)
15
Gonzalez H.D., Figueras J. Effect of surgical resection of metastatic disease on immune tolerance to cancer. How a systemic disease could be controlled by a local therapy // Clin. Transl. Oncol. – 2007. – Vol. 9. – P. 571-577.
(check this in PDF content)
16
Gupta D., Lis C.G. Role of CA-125 in predicting ovarian cancer survival – a review of the epidemiological literature // J. Ovarian. Res. – 2009. – Vol. 2: 13 (BioMed Central http://www. ovarianresearch.com/content/2/1/13).
(check this in PDF content)
17
Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3 // Science. – 2003. – Vol. 299. – P. 1057-1061.
(check this in PDF content)
18
Jonuleit H., Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. // J. Immunol. – 2003. – Vol. 171. – P. 6323-6327.
(check this in PDF content)
19
Kono K., Kawaida H., Takahashi A., Sugai H., Mimura K., Miyagawa N., Omata H., Fujii H. CD4+CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers // Cancer Immunol. Immunother. – 2006. – Vol. 55, N. 9. – P. 1064-1071.
(check this in PDF content)
20
Münstedt K., Krisch M., Sachsse S., Vahrson H. Serum CA-125 levels and survival in advanced ovarian cancer // Arch. Gynecol. Obstet. – 1997. – Vol. 259. – P. 117-123
(check this in PDF content)
21
Shafer-Weaver K.A, Anderson M.J., Stagliano R., Malyguine A., Greenberg N.M., Hurwitz A.A Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells // J. Immunol. – 2009. – Vol. 183, N 8. – P. 4848-4852.
(check this in PDF content)
22
Shimizu J., Yamazaki S., Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells a common basis between tumor immunity and autoimmunity // J. Immunol. – 1999. – Vol. 163. – P. 5211- 5218.
(check this in PDF content)
23
Tokuno K., Hazama S., Yoshino S., Yoshida S., Oka M. Increased prevalence of regulatory T-cells in the peripheral blood of patients with gastrointestinal cancer // Anticancer Res. – 2009. – Vol. 29, N 5. – P. 1527-1532.
(check this in PDF content)
24
Walker M. R., Carson B.D., Nepom G.T., Ziegler S.F., Buckner J.H. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25– cells // Proc. Natl. Acad. Sci. USA. – 2005. – Vol. 102. – P. 4103-4108.
(check this in PDF content)
25
Wei S., Kryczek I., Zou W. Regulatory T-cells compartmentalization and trafficking // Blood. – 2006. – Vol. 108. – P. 426-431.
(check this in PDF content)
26
Zhou G., Levitsky H.I. Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance // J. Immunol. – 2007.-Vol. 178. – P. 2155-2162.
(check this in PDF content)
27
Zou W. Regulatory T cells, tumor immunity and immunotherapy // Nat. Rev. Immunol. – 2006. – Vol. 6. – P. 295-307. поступила в редакцию 31.03.2010 отправлена на доработку 19.04.2010
(check this in PDF content)